SHIONOGI & CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,306 JPY | +2.21% |
|
+2.70% | +7.47% |
| Apr. 25 | Shionogi & Co., Ltd. Revises Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024 | CI |
| Apr. 19 | Shionogi & Co Completes Cancellation of 10.84 Million Treasury Shares | MT |
ETFs positioned on Shionogi & Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.69% | 15 M€ | +7.34% | ||
| 2.51% | 5 M€ | +6.26% | - | |
| 1.07% | 60 M€ | +14.42% | ||
| 1.05% | 11 M€ | +10.37% | - | |
| 1.04% | 251 M€ | +13.17% | ||
| 0.92% | 67,864 M€ | +14.28% | ||
| 0.86% | 15 M€ | +14.10% | ||
| 0.85% | 31,732 M€ | +14.31% | - | |
| 0.85% | 1,198 M€ | +13.48% | - | |
| 0.84% | 51 M€ | -.--% | - | |
| 0.84% | 174 M€ | -.--% | - | |
| 0.72% | 16,729 M€ | +13.38% | - | |
| 0.61% | 2 M€ | -.--% | - | |
| 0.61% | 2 M€ | +9.19% | - | |
| 0.59% | 73 M€ | +11.61% | ||
| 0.54% | 81 M€ | +14.05% | ||
| 0.40% | 14 M€ | +15.63% | ||
| 0.38% | 18 M€ | +16.15% | - | |
| 0.36% | 10,207 M€ | +14.32% | ||
| 0.36% | 5,115 M€ | +13.58% | ||
| 0.34% | 26 M€ | +20.62% | ||
| 0.26% | 66,066 M€ | +14.68% | - | |
| 0.26% | 144,586 M€ | +14.49% | ||
| 0.26% | 20,721 M€ | +13.52% | - | |
| 0.10% | 4 M€ | -.--% | - | |
| 0.08% | 7 M€ | +1.95% | - | |
| 0.07% | 10 M€ | -3.35% | - | |
| 0.06% | 7 M€ | +0.11% | - | |
| 0.06% | 277 M€ | -.--% | - | |
| 0.05% | 194 M€ | +7.48% | - |
Shionogi & Co., Ltd. specializes in development, manufacturing and marketing of pharmaceutical products. The group's activity is organized around 3 families of products:
- prescription products: drugs for the treatment of cardiovascular and infectious diseases, diabetes, allergic reactions, etc.;
- OTC products: analgesic products, vitamins and tonics, etc.;
- diagnosis products: primarily for detection and treatment of cardiovascular diseases and immune system.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q4 2023 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
7,306
JPY
Average target price
7,721
JPY
Spread / Average Target
+5.68%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.47% | 13.16B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 4507 Stock
- Funds and ETFs Shionogi & Co., Ltd.
